XML 30 R15.htm IDEA: XBRL DOCUMENT v3.26.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 3 – FAIR VALUE MEASUREMENTS

 

As of December 31, 2025 and 2024, the carrying amounts of accounts payable, accounts receivable and other receivables approximate their fair values due to the short-term maturities of these instruments.

 

The carrying amount of the long-term deposit approximates its fair value since it is measured at its present value applying prevailing interest rates, see note 7.

 

The Company’s financial assets subject to fair value measurements on a recurring basis and the level of inputs used in such measurements were as follows:

 

   Total   Level 1   Level 2   Level 3 
  

As of December 31, 2025

($ in thousands)

 
   Total   Level 1   Level 2   Level 3 
                 
Assets:                    
Cash equivalents-                    
Money market funds  $5,116   $5,116   $-   $- 
                     
Marketable securities-                    
U.S government bonds  $45,272   $-   $45,272   $- 

 

   Total   Level 1   Level 2   Level 3 
  

As of December 31, 2024

($ in thousands)

 
   Total   Level 1   Level 2   Level 3 
                 
Assets:                    
Cash equivalents-                    
Money market funds  $6,281   $6,281   $-   $- 
                     
Marketable securities-                    
U.S. government bonds  $15,721   $-   $15,721   $- 

 

The Company’s cash equivalents and marketable securities are classified within Level 1 and Level 2 because it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair value.

 

The cost of marketable securities as of December 31, 2025, and 2024 is $45,091 and $15,277 thousand, respectively.

 

 

INSPIREMD, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (continued)